Cargando…

The expression of AURKA is androgen regulated in castration-resistant prostate cancer

Although second generation endocrine therapies have significantly improved survival, castration-resistant prostate cancer (CRPC) cells are eventually able to escape available hormonal treatments due to reactivation of androgen receptor (AR) signaling. Identification of novel, non-classical and drugg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kivinummi, Kati, Urbanucci, Alfonso, Leinonen, Katri, Tammela, Teuvo L. J., Annala, Matti, Isaacs, William B., Bova, G. Steven, Nykter, Matti, Visakorpi, Tapio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740165/ https://www.ncbi.nlm.nih.gov/pubmed/29269934 http://dx.doi.org/10.1038/s41598-017-18210-3

Ejemplares similares

DOT1L-HES6 fusion drives androgen independent growth in prostate cancer
por: Annala, Matti, et al.
Publicado: (2014)

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
por: Kallio, Heini M. L., et al.
Publicado: (2018)

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer
por: Sjöblom, Liisa, et al.
Publicado: (2016)

Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
por: Latonen, Leena, et al.
Publicado: (2018)

Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer
por: Bova, G. Steven, et al.
Publicado: (2016)

Epigenetically altered miR-193b targets cyclin D1 in prostate cancer
por: Kaukoniemi, Kirsi M, et al.
Publicado: (2015)

Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer
por: Annala, Matti, et al.
Publicado: (2015)

Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases
por: Sattari, Mina, et al.
Publicado: (2023)

Androgen regulation of the androgen receptor coregulators
por: Urbanucci, Alfonso, et al.
Publicado: (2008)

Proteomics of prostate cancer – revealing how cancer cells master their messy genomes
por: Latonen, Leena, et al.
Publicado: (2018)

Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen
por: Kukkonen, Konsta, et al.
Publicado: (2022)

Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation
por: Nätkin, Reetta, et al.
Publicado: (2023)

Feature-based analysis of mouse prostatic intraepithelial neoplasia in histological tissue sections
por: Ruusuvuori, Pekka, et al.
Publicado: (2016)

Analysis of spatial heterogeneity in normal epithelium and preneoplastic alterations in mouse prostate tumor models
por: Valkonen, Mira, et al.
Publicado: (2017)

The Evolutionary History of Lethal Metastatic Prostate Cancer
por: Gundem, Gunes, et al.
Publicado: (2015)

Expression and ERG regulation of PIM kinases in prostate cancer
por: Eerola, Sini K., et al.
Publicado: (2021)

CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations
por: Khanna, Anchit, et al.
Publicado: (2015)

Segmentum: a tool for copy number analysis of cancer genomes
por: Afyounian, Ebrahim, et al.
Publicado: (2017)

Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas
por: Lehtinen, Birgitta, et al.
Publicado: (2017)

Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas
por: Granberg, Kirsi J, et al.
Publicado: (2017)

Overall and worst gleason scores are equally good predictors of prostate cancer progression
por: Tolonen, Teemu T, et al.
Publicado: (2011)

Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer
por: Rantapero, Tommi, et al.
Publicado: (2020)

Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response
por: Kukkonen, Konsta, et al.
Publicado: (2021)

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine
por: Nurminen, Anssi, et al.
Publicado: (2023)

A Linear Model for Transcription Factor Binding Affinity Prediction in Protein Binding Microarrays
por: Annala, Matti, et al.
Publicado: (2011)

Mapping of the chromosomal amplification 1p21-22 in bladder cancer
por: Scaravilli, Mauro, et al.
Publicado: (2014)

Comparative analysis of tissue reconstruction algorithms for 3D histology
por: Kartasalo, Kimmo, et al.
Publicado: (2018)

CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine
por: Chen, Xi, et al.
Publicado: (2022)

Spatial analysis of histology in 3D: quantification and visualization of organ and tumor level tissue environment
por: Ruusuvuori, Pekka, et al.
Publicado: (2022)

Frequent mutation of the FOXA1 untranslated region in prostate cancer
por: Annala, Matti, et al.
Publicado: (2018)

Reciprocal deregulation of NKX3.1 and AURKA axis in castration-resistant prostate cancer and NEPC models
por: Sooreshjani, Moloud Aflaki, et al.
Publicado: (2021)

Construction of therapeutically relevant human prostate epithelial fate map by utilising miRNA and mRNA microarray expression data
por: Rane, Jayant K, et al.
Publicado: (2015)

Fanconi anemia pathway regulation by FANCI in prostate cancer
por: Kaljunen, Heidi, et al.
Publicado: (2023)

Gene Regulation Network Analysis on Human Prostate Orthografts Highlights a Potential Role for the JMJD6 Regulon in Clinical Prostate Cancer
por: Cangiano, Mario, et al.
Publicado: (2021)

Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer
por: Taavitsainen, Sinja, et al.
Publicado: (2019)

Contribution of ARLTS1 Cys148Arg (T442C) Variant with Prostate Cancer Risk and ARLTS1 Function in Prostate Cancer Cells
por: Siltanen, Sanna, et al.
Publicado: (2011)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer
por: Barfeld, Stefan J., et al.
Publicado: (2015)

Molecular Interplay between AURKA and SPOP Dictates CRPC Pathogenesis via Androgen Receptor
por: Nikhil, Kumar, et al.
Publicado: (2020)

Evaluation of the Association between Androgen Receptor and AURKA and Its Prognostic Value in Gastric Cancer
por: Soleymani Fard, Shahrzad, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3dm2lromb6mei1ccasealj6181